Implications of ARRA for Clinical Decision Support

Editorial Staff | | Health Exec | Precision Medicine
Implications of ARRA for Clinical Decision Support Monday, March 1, 11:00 AM - 12:00 PM

Clinical decision support may be relevant to the demonstration of meaningful use for the American Recovery and Reinvestment Act. The presenters will discuss the potential implications of this relationship.

Speaker Information:
Loran Hauck, MD
Senior Vice President, Office of Clinical Effectiveness & CMO, Adventist Health System
Scott Weingarten, MD, MPH
President and Chief Executive Officer, Zynx Health

Editorial Staff

Related Content

Pitching the business case for 3D printing labs in radiology
FDA issues first-ever clearance for OTC oximeter
Augmented reality company secures $15M in funding from Cleveland Clinic, Mayo, GE Healthcare and more
Merck to acquire Prometheus Biosciences for $10.8B
Johnson & Johnson scraps RSV vaccine after trial
Intermountain Health launches new biotech company

Around the web

Cardiovascular Business
Q&A: MedAxiom CEO explores key trends in cardiologist, cardiovascular surgeon compensation

Compensation for heart specialists continues to climb. What does this say about cardiology as a whole? Could private equity's rising influence bring about change? We spoke to MedAxiom CEO Jerry Blackwell, MD, MBA, a veteran cardiologist himself, to learn more.

Cardiovascular Business
Payment cuts and beyond: Key takeaways for cardiologists from the 2025 Medicare Physician Fee Schedule

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

AI in Healthcare
A modest proposal to rally AI regulators around a simple game plan

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”